US Thrombotic Microangiopathy Alliance

Analysis

US Thrombotic Microangiopathy Alliance is a registered charity in United States, based in Groveport, OH. It received its IRS tax-exemption ruling in December 2019, 7 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, US Thrombotic Microangiopathy Alliance reported income of $1.9m and spending of $669k, leaving 64% of income unspent that year. Across the 2 years on record, from December 2022 to December 2023, income grew from $950k to $1.9m (+96%), an average of +96% a year. The sharpest change came in the year to December 2023, when income rose by 96%. Over the whole period it spent 34% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, US Thrombotic Microangiopathy Alliance sits at the 71st percentile: it is larger than about 71% of them. Against every charity in United States with reported income it ranks in the 85th percentile, and in the 85th percentile within OH. Charities of a similar size with the same main cause include Northwest Youth Discovery Inc ($1.9m), Missouri Immunization Coalition ($1.9m) and Coalition of State Rheumatology Organizations Inc ($1.9m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 31% and program service revenue 69% of the total. Compensation of current officers, directors and key employees was $108k (16% of expenses). At year end it held assets of $2.1m against liabilities of $69k, net assets of $2.0m. It reported 2 employees.